PICO Portalanswers from OpenAlex & ORCID
David D. Stenehjem
ResearcherPublications, citations & collaboration network
David D. Stenehjem is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does David D. Stenehjem have?
PICO Portalindexed works
David D. Stenehjem has 244 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David D. Stenehjem have?
PICO Portalcitation count
David D. Stenehjem has 2,848 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of David D. Stenehjem?
PICO Portalh-index
David D. Stenehjem has an h-index of 23 in OpenAlex.
What is the i10-index of David D. Stenehjem?
PICO Portali10-index
David D. Stenehjem has an i10-index of 47 in OpenAlex.
What is the ORCID of David D. Stenehjem?
PICO Portalorcid
The ORCID for David D. Stenehjem is on the source record.
What is the OpenAlex record for David D. Stenehjem?
PICO Portalopenalex
The OpenAlex for David D. Stenehjem is on the source record.
What are the most-cited papers on David D. Stenehjem?
PICO Portalmost cited works
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, Elizabeth A. Sexton, David D. Stenehjem, Wojtek Wiercioch, Lara A Kahale, Pablo Alonso‐Coello
Diagnosis and treatment of cancer‐related anemia
Jeffrey A. Gilreath, David D. Stenehjem, George M. Rodgers
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
David D. Stenehjem, Dao Tran, Michael Nkrumah, Shilpa Gupta
Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer
David Waterhouse, Jenny Lam, Keith A. Betts, Lei Yin, Sophie Gao, Yong Yuan, John Hartman, Sumati Rao, Solomon J. Lubinga, David D. Stenehjem
Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
Jason I. Griffiths, Pierre Wallet, Lance Pflieger, David D. Stenehjem, Xuan Liu, Patrick A. Cosgrove, Neena A. Leggett, Jasmine A. McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J. Moos, Frederick R. Adler, Jeffrey T. Chang, Sunil Sharma, Andrea H. Bild